or Try an Advanced Search...

    Technical Analysis for ALEC - Alector, Inc.

    Grade Last Price % Change Price Change
    F 4.42 -2.64% -0.12
    ALEC closed down 2.64 percent on Monday, July 1, 2024, on 69 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical ALEC trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    20 DMA Resistance Bearish -2.64%
    Volume Surge Other -2.64%
    20 DMA Resistance Bearish -3.70%
    Shooting Star Candlestick Bearish -3.70%
    MACD Bullish Signal Line Cross Bullish -3.70%
    Doji - Bearish? Reversal -3.70%
    Slingshot Bearish Bearish Swing Setup -3.28%
    Pocket Pivot Bullish Swing Setup -3.28%
    Volume Surge Other -3.28%
    Older End-of-Day Signals for ALEC ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 4 hours ago
    Possible NR7 about 6 hours ago
    Fell Below 10 DMA about 8 hours ago
    10 DMA Support about 8 hours ago
    Down 2 % about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ALEC Chart by TradingView
    Basic chart:

    Profile

    Alector is pioneering immuno-neurology, a novel therapeutic approach to counteract the multiple pathologies that cause degenerative brain disorders by restoring healthy immune function to the brain. Supporting its scientific approach, the Company’s Discovery Platform enables them to advance a broad portfolio of product candidates, validated by human genetics, which they believe will improve the probability of technical success of these product candidates and shorten the development timelines to bring these therapies to patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Immune System Genetics Urology Neurology Brain Disorders

    Is ALEC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 30 Why Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?
    Jun 24 Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
    Jun 20 Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    Jun 10 Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
    Jun 3 Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 11 Here's Why We're Watching Alector's (NASDAQ:ALEC) Cash Burn Situation
    May 8 Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
    May 8 Alector GAAP EPS of -$0.38 beats by $0.16, revenue of $15.89M beats by $0.13M
    May 8 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
    Apr 25 Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
    See more ALEC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.065
    52 Week Low 3.66
    Average Volume 653,812
    200-Day Moving Average 5.89
    50-Day Moving Average 4.96
    20-Day Moving Average 4.54
    10-Day Moving Average 4.44
    Average True Range 0.29
    RSI (14) 42.86
    ADX 14.59
    +DI 24.40
    -DI 23.58
    Chandelier Exit (Long, 3 ATRs) 4.26
    Chandelier Exit (Short, 3 ATRs) 4.99
    Upper Bollinger Bands 4.98
    Lower Bollinger Band 4.11
    Percent B (%b) 0.36
    BandWidth 19.18
    MACD Line -0.17
    MACD Signal Line -0.19
    MACD Histogram 0.0242
    Fundamentals Value
    Market Cap 419.93 Million
    Num Shares 95 Million
    EPS -1.71
    Price-to-Earnings (P/E) Ratio -2.58
    Price-to-Sales 6.36
    Price-to-Book 3.77
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.80
    Resistance 3 (R3) 4.83 4.74 4.73
    Resistance 2 (R2) 4.74 4.64 4.72 4.71
    Resistance 1 (R1) 4.58 4.59 4.54 4.55 4.69
    Pivot Point 4.49 4.49 4.47 4.47 4.49
    Support 1 (S1) 4.33 4.39 4.29 4.30 4.15
    Support 2 (S2) 4.24 4.34 4.22 4.13
    Support 3 (S3) 4.08 4.24 4.11
    Support 4 (S4) 4.05